Towards Healthcare

NEWS & INSIGHTS

Stay ahead of the curve with in-depth coverage of the latest breakthroughs, emerging trends, strategic developments, and transformative innovations shaping the future of healthcare, science, technology, and global business.

New data highlights BCL's additional improvement, benefiting surgeons
Date 27 October 2025

New data highlights BCL's additional improvement, benefiting surgeons

Image Credit: CCO Announcement  Cairn Surgical Inc., a leading creative medical technology company, actively participates in making breast cancer surgery more accurate, informed that the mult...

Novo Nordisk's oral semaglutide confirmed for CV risk reduction
Date 24 October 2025

Novo Nordisk's oral semaglutide confirmed for CV risk reduction

Image Credit: ChemXplore Announcement  Novo Nordisk received approval from the US Food and Drug Administration (FDA) for Rybelsus. The Rybelsus® is the first ever GLP-1 medication for all...

AB Science's initial phase one data (update) on the AB8939 program in AML disclosed
Date 22 October 2025

AB Science's initial phase one data (update) on the AB8939 program in AML disclosed

Image Credit: americanbuilt. app Announcement  AB Science, a leading French pharmaceutical company, aims to establish novel drugs to offer unmet medical needs for conditions like neurology, i...

Arima Genomics' new study shows multipurpose advantage
Date 20 October 2025

Arima Genomics' new study shows multipurpose advantage

Image Credit: Yahoo Finance Announcement  The Arima Genomics, Inc., a leading structure information and whole-genome sequence-focused company serving robust cancer therapy selection insights,...

IGC Pharma extends its phase 2 CALMA clinical trial
Date 17 October 2025

IGC Pharma extends its phase 2 CALMA clinical trial

Image Credit: Morningstar Announcement  The IGC Pharma Inc., the leading clinical-level biotechnology company accelerating AI to establish creative alternative treatments for alzheimer’...

Repare Therapeutics to introduce primary data from its clinical trial
Date 16 October 2025

Repare Therapeutics to introduce primary data from its clinical trial

Image Credit: Stock Events Announcement  Repare Therapeutics Inc., a leading clinical-level precision oncology company, has presented primary data on excellent tolerability, early efficacy, a...

HUTCHMED showcased its registration clinical trial data, focusing merger drug
Date 15 October 2025

HUTCHMED showcased its registration clinical trial data, focusing merger drug

Announcement  The HUTCHMED (China) Limited, a leading commercial-level, innovative biopharmaceutical company, declared its results from the FRUSICA-2 registration clinical trial of the sintili...

ViiV showcased the potential of its clinical-proven study
Date 14 October 2025

ViiV showcased the potential of its clinical-proven study

Image Credit: ViiV Healthcare Announcement  The ViiV Healthcare, a leading worldwide HIV specialist company owned by GSK, along with Shionogi and Pfizer as the shareholders, showcased a clini...

Sanofi enters the realm of radiopharma with a competition to Novartis
Date 13 October 2025

Sanofi enters the realm of radiopharma with a competition to Novartis

Image Credit: Medcity News Announcement  Sanofi’s Orano breakthrough radioligand therapy, Alphamedix, has successfully passed the efficacy test, meeting an excellent endpoint. Involving...

nChroma to receive approval for abstracts at the meeting of the AASLD
Date 10 October 2025

nChroma to receive approval for abstracts at the meeting of the AASLD

Announcement  The nChroma Bio, a leading genetic medicines company developing in vivo delivery of unique cargoes to address the limitations of the previous therapies, has received approval for...

Ready to make better
healthcare business decisions?

Speak with a healthcare analyst about your research, consulting, or platform needs.